Date: 04 February 2021
Duration: 1 day
Cost: Please visit the website for more details.
3D printing is making a name for itself in medicine manufacturing. While it’s hard to foresee the wholesale replacement of current tablet manufacturing processes, 3D printing is expected to find a place in certain niche medications and in personalised tablets.
For so-called orphan drugs, the inherent versatility of 3D printing is particularly appealing. Rather than the current situation of pharmaceutical companies needing to maintain expensive specialist infrastructure to manufacture medicines of which low numbers are sold, it is theoretically possible to print many different types of tablets by simply changing the powder used, or even by just changing the ‘ink cartridges’ in commercially available 3D printers.
This ink cartridge concept also offers the possibility of decentralising tablet manufacture in certain circumstances. It also opens up the possibility of using 3D printing in personalised medicine – to produce a tablet designed to meet the needs of a single patient, the drug loading, combination of drugs and the release profile of the formulation.
This conference (1st edition in 2017), which is part of the 3D Medical Printing Series, will bring together the international Pharmaceutical community to showcase the work of researchers and industry in the 3D Pharmaceutical Printing field and its applications, with a view to fostering closer ties and collaborations. The overall goal of this conference is to address both the technologies and the applications — from early technology development to downstream applications.
Early-stage and Start-Up Companies will find this conference an excellent source of networking opportunities with key opinion leaders participating and speaking.